Results of subgroup analysis of the HELIOS trial
Results of subgroup analysis of the HELIOS trial
Primary results from the MABLE phase IIIb study
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors
Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy
A laboratory model of the hypoxic tumour microenvironment
Will chemotherapy remain the cornerstone of CLL management?
New research into new small molecule IKKα inhibitors
Phase II study of idelalisib monotherapy in older CLL patients
History of the B-cell in its 50th anniversary year
Human B-cell receptor structure and function in CLL
Translational research and the future of CLL treatment
The role of CLL cells, T-cells and macrophages and their effects on the tumour microenvironment